Obimet GX Forte 3mg Tablet SR is a combination oral hypoglycemic agent containing Glimepiride 3mg and Metformin 1000mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class drug, stimulates pancreatic beta cells to enhance insulin secretion, thereby improving glycemic control. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving peripheral insulin sensitivity, contributing to better glucose uptake and utilization. The sustained-release formulation ensures a gradual release of active ingredients, promoting consistent plasma drug levels and reducing gastrointestinal side effects commonly associated with immediate-release metformin. Obimet GX Forte is prescribed as an adjunct to diet and exercise to achieve optimal blood glucose regulation in patients inadequately controlled by monotherapy. It is essential to monitor blood glucose levels regularly and adjust dosage based on therapeutic response and tolerability. Caution is advised in patients with renal or hepatic impairment, and contraindications include conditions predisposing to lactic acidosis. Common adverse effects may include hypoglycemia, gastrointestinal disturbances, and, rarely, lactic acidosis. Patient education on adherence, lifestyle modification, and recognition of hypoglycemic symptoms is critical to maximize therapeutic outcomes with Obimet GX Forte 3mg Tablet SR.